Search results for PX-TA1392
Showing 1 – 10 of1products
ID: BAB930767714
Monalizumab Biosimilar – Anti-KLRC1, NKG2A, CD159a, CD94 mAb – Research Grade, ProteoGenix, PX-TA1392
Description of Monalizumab Biosimilar - Anti-KLRC1, NKG2A, CD159a, CD94 mAb - Research Grade General information on Anti-KLRC1/NKG2A/CD159a/CD94[Homo sapiens] (Monalizumab) Monoclonal Antibody Monalizumab has been investigated for the treatment of Gynecologic Cancer, Chronic Lymphocytic Leukemia, and Squamous Cell Carcinoma of the Oral Cavity.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.